|
27/12/2016 |
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
CPN |
Registered |
|
12/10/2016 |
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer |
CIM |
Registered |
|
22/11/2013 |
hR3 in metastatic or recurrent colorectal cancer |
CIM |
Registered |
|
14/11/2014 |
Study in Hematological Malignancies |
CIGB |
Registered |
|
09/10/2014 |
Insufflation with CO2 versus room air in colonoscopy |
CNCMA |
Registered |
|
26/05/2014 |
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. |
CIM |
Registered |
|
05/08/2014 |
CIMAVax EGF in Lung Cancer in PHC. Phase IV |
CIM |
Registered |
|
11/03/2016 |
Biograft-G in Dentistry |
BIOMAT |
Registered |
|
27/09/2017 |
Bioequivalence of Abacavir |
CIDEM |
Registered |
|
16/02/2017 |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CIGB |
Registered |
|
06/08/2014 |
Heptavalent Conjugate Vaccine against Pneumococcal (VCN7-T) in healthy children. |
CQB |
Registered |
|
23/04/2014 |
CIGB-500 in acute myocardial infarction (AMIGOS study) |
CIGB |
Registered |
|
27/06/2014 |
D-002 and glucosamine/chondroitin sulphate in osteoarthritis |
CPN |
Registered |
|
11/09/2014 |
NeuroEPO-Stroke. Phase I-II |
CIMAB |
Registered |
|
02/11/2014 |
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |
CIMAB |
Registered |
|
22/05/2015 |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
CIM |
Registered |
|
29/01/2016 |
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
CIM |
Registered |
|
17/02/2017 |
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
|
06/11/2014 |
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . |
FINLAY |
Registered |
|
10/11/2014 |
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
CIGB |
Registered |
